PPARs and Anticancer Therapies.
作者信息
Robbins Michael E C, Linard Christine, Panigrahy Dipak
机构信息
Department of Radiation Oncology, Brain Tumor Center of Excellence, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
出版信息
PPAR Res. 2010;2010:536415. doi: 10.1155/2010/536415. Epub 2010 Jun 8.
Abstract
摘要
相似文献
1
PPARs and Anticancer Therapies.
PPAR Res. 2010;2010:536415. doi: 10.1155/2010/536415. Epub 2010 Jun 8.
2
Corrigendum to "PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors".
PPAR Res. 2019 Jul 21;2019:4309068. doi: 10.1155/2019/4309068. eCollection 2019.
3
Peroxisome proliferator-activated receptors (PPARs) in health and disease.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002 Dec;146(2):11-4. doi: 10.5507/bp.2002.002.
4
Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
Eur J Med Chem. 2017 Dec 1;141:162-168. doi: 10.1016/j.ejmech.2017.09.071. Epub 2017 Sep 30.
5
The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure.
Curr Pharm Des. 2017;23(11):1677-1686. doi: 10.2174/1381612822666160928150040.
6
The mechanisms of action of PPARs.
Annu Rev Med. 2002;53:409-35. doi: 10.1146/annurev.med.53.082901.104018.
7
[Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
Rev Invest Clin. 2004 May-Jun;56(3):351-67.
8
Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology.
PPAR Res. 2018 Dec 5;2018:8530371. doi: 10.1155/2018/8530371. eCollection 2018.
9
Peroxisome proliferator-activated receptors in the regulation of female reproductive functions.
Folia Histochem Cytobiol. 2015;53(3):189-200. doi: 10.5603/fhc.a2015.0023. Epub 2015 Sep 4.
10
[PPARs, metabolic syndrome and cardiac diseases].
Arch Cardiol Mex. 2007 Oct-Dec;77 Suppl 4:S4-66-76.
引用本文的文献
1
PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1.
PPAR Res. 2016;2016:2612743. doi: 10.1155/2016/2612743. Epub 2016 Aug 2.
2
Rosiglitazone accentuates the adipogenesis of hemangioma-derived mesenchymal stem cells induced by adipogenic media.
Int J Clin Exp Med. 2014 Jul 15;7(7):1741-6. eCollection 2014.
3
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.
Br J Pharmacol. 2011 Sep;164(1):68-82. doi: 10.1111/j.1476-5381.2011.01383.x.
Zotero 插件